When you are a big fund and worried about putting capital to work, the easiest thing to do is buy the FAANG stocks.
YEXT is one of the few breakouts that is not also overbought technically.
Despite the January rally, this biotech name and building materials firm still have further to rise.
The data is increasingly suggesting a pause/retracement of January's gains. Get ready for it.
And why maintaining a small position in defense stocks is important.
2018's Christmas Eve capitulation turned out to be the best buying opportunity since March 2009.
Buckle up after Super Sunday.
RMPIA soared 9.9% for the month, led by 11 double-digit gainers.
Dividend reinvestment plans (DRIPs) are compound interest to the extreme. Here are an expert's top-10 DRIP stocks for 2019.
This earnings season can best be described as 'better than feared.'